Sinofn Health
Sinofn Health
In the post-pandemic era, global enterprise procurement has shifted focus from pure cost-reduction to supply chain resiliency. SINOFN utilizes "China Factory 4.0" standards, integrating IoT-driven production, blockchain-verified batch tracking, and rigorous compliance with international standards (FSSC 22000, ISO 22000). We are not just a manufacturer; we are a strategic partner providing localized application scenarios for global brands.
Search intent mining reveals that buyers are no longer looking for generic OEM services. They seek specialized formulation capabilities. By leveraging our partnership with the Chinese Academy of Sciences and our Tianjin R&D center, SINOFN provides technical deep-dives into bioavailability, stability, and formulation optimization that competitors simply cannot offer.
Director of SINOFN Medical Innovation Dept. Ph.D from Peking University Medical School. 15+ years in metabolic disorder formulations.
R&D Lead, CAS Postdoctoral Fellow. Specialist in advanced bioactive compound delivery systems and molecular stability.
Formulation Director (Netherlands). Senior Scientist expert in EU regulatory compliance and nutraceutical scaling.
We implement a triple-layer QA system: HPLC/GC-MS contaminant screening, microbiological safety testing, and real-time stability monitoring. Every batch is traceable via blockchain.
Yes. Our R&D center is equipped with pilot-scale prototyping lines specifically for tablets, capsules, and liquids, allowing for rapid iteration before full-scale manufacturing.
Our deep expertise in Foods for Special Medical Purposes (FSMP) means we approach general nutraceuticals with pharmaceutical-grade precision and safety standards.
